VU Venture Partners
VC Fund
San Francisco, United States
VU Venture Partners is a multi-stage venture capital fund focusing on Consumer, Enterprise, FinTech / Blockchain, HealthTech, Frontier Tech, and Real Estate Tech. It was founded in 2018 and is based in San Francisco, California.
- Total investments:
- 116
- Last investment:
- Lead investor:
- 2%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries VU Venture Partners invests in
Stages VU Venture Partners invests in
Countries VU Venture Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.4M–$9M
- Series A
- $5M–$64M
Investment Focus
Industry
- Health Care 17 (15%)
- Software 16 (14%)
- Biotechnology 12 (10%)
- Artificial Intelligence 11 (9%)
- Machine Learning 10 (9%)
Stage
- Seed 36 (31%)
- Funding Round 24 (21%)
- Series A 23 (20%)
- Venture - Series Unknown 8 (7%)
- Series B 4 (3%)
Country
- United States 51 (44%)
- United Kingdom 4 (3%)
- Colombia 3 (3%)
- India 2 (2%)
- Canada 2 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
J. Skyler Fernandes
Co-Founder & General Partner
|
Co-Founder & General Partner | Total investments: 3 | Find email | |
|
Alessandra Habermann
Senior Associate
|
Senior Associate | Total investments: 0 | Find email | |
Alfredo Mercedes
Head of Talent
|
Head of Talent | Total investments: 0 | Find email | |
Andrew Lopez-Gallego
VC Investor
|
VC Investor | Total investments: 0 | Find email | |
Arpan Ajmera
Associate
|
Associate | Total investments: 1 | Find email | |
| See all 15 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ALKEMIO
|
ALKEMIO is a developer of a bio-magnetic technology intended to transform electronic waste into quality battery-grade metals. | $2M / Seed / Mar 31, 2026 | |
HEARTio
|
HEARTio is a digital diagnostic startup using artificial intelligence to help emergency providers identify heart abnormalities more quickly, more accurately, and for orders of magnitude less. It was started in 2018 and is headquartered in Pittsburgh, Pennsylvania. | $4.3M / Seed / Mar 16, 2026 | |
Natilus
|
Natilus is a large scale drone manufacturing company. The company specializes in the manufacturing of Boeing 747 sized drones which provides inter-continental cargo delivery services and helps in reducing air freight costs. Natilus was founded by LZ Zhang, Anatoly Starikov and Aleksey Matyushev in 2016.First flight of their 2200 lbs / 30 ftdrone is scheduled for Summer 2018. At the end of 2018, Natilus completed a flight test of their 2200 lbs prototype.The first production vehicle scheduled for 2020 customer delivery underwent wind tunnel testing in April, 2019. Natilus currently holds an aircraft order book rumored to be in excess of $1B+. | $28M / Series A / Feb 10, 2026 | |
Atomionics
|
Atomionics is building atomic sensors for navigation and resource exploration. Sensing technology is severely inadequate for a lot of applications navigation and positioning, pinpointing oil and gas reserves, tunnel detection etc. Atomionics builds atomic sensors harnessing quantum mechanical properties of the atoms. This enables measurement ofparameters like gravity, acceleration and rotation with 1000x higher precision and accuracy than the current state of the art, leading to a completely new way of global positioning, and resource exploration. | $12.7M / Seed / Sep 08, 2025 | |
JumpStart Fertility
|
Jumpstart Fertility is investigating novel techniques to aid patients in starting or continuing to increase their families, including approaches that address the effects of biological aging on assisted reproduction. We want to increase IVF success rates so that patients need fewer cycles to get a healthy pregnancy. Our research focuses onenhancing egg quality and embryo development in IVF cycles in later age groups, where IVF success rates tend to drop, necessitating repeated rounds under existing standards of care. | $2.6M / Venture - Series Unknown / Jun 09, 2025 | |
Wegrow-app
|
Wegrow is an AI software company that offers AI agents for business solutions. It uses AI to identify best practices for marketing, sales, IT, Finance, HR, and Supply Chain departments and turn them into business results. | $7.8M / Series A / Sep 18, 2024 | |
Healx
|
Healx is a mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are 7,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AItechnology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact. Founded in Cambridge, UK, in 2014 by Dr Tim Guilliams (a Biochemical Engineer and tech entrepreneur) and Dr David Brown (co-inventor of Viagra and former Global Head of Drug Discovery at Roche), Healx has raised $70 million to date. For more information, visit www.healx.io. | $47M / Series C / Aug 01, 2024 | |
Cellbricks Therapeutics
|
Cellbricks offers plastic surgery and transplant medicine that rely on artificial materials devoid of physiological functions or immunosuppressive transplants from human and animal sources. It offers the bio-fabrication of human tissue and organs, a widespread medical procedure that enables people to live longer and in better condition. | Venture - Series Unknown / Apr 23, 2024 | |
Orchard Robotics
|
Orchard Robotics develops an operating system that enables precision agriculture driven by robots and AI. Its camera systems and computer vision software gather precise data for the visible fruit on any tree. It is utilized by growers, packers, and marketers to manage crop load and supply chains. | $3.2M / Seed / Mar 27, 2024 | |
Isaac Health
|
Isaac Health aims to democratize access to specialist dementia prevention and management through a virtual membership platform. It features a program of neuropsychological assessments, neurology telemedicine consults and memory coaching. | $5.7M / Seed / Jan 25, 2024 | |
| See all 116 investments → | |||
Co-Investors
Venture University
31 deals together
Bias Capital
6 deals together
SOSV
5 deals together
Y Combinator
5 deals together
Flucas Ventures
4 deals together
UntroD Capital
4 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does VU Venture Partners invest in?
VU Venture Partners invests primarily in Health Care, Software and Biotechnology startups, most often at Seed and Funding Round stage. Most of the 116 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is VU Venture Partners's check size?
VU Venture Partners typically joins rounds of $1.4M–$9M at Seed and $5M–$64M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds VU Venture Partners participates in.
How do I contact VU Venture Partners?
Public channels for VU Venture Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at VU Venture Partners?
The team at VU Venture Partners includes J. Skyler Fernandes (Co-Founder & General Partner), Alessandra Habermann (Senior Associate) and Alfredo Mercedes (Head of Talent), among 15 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
